SOPHiA GENETICS (SOPH) to Release Quarterly Earnings on Tuesday

SOPHiA GENETICS (NASDAQ:SOPHGet Free Report) is anticipated to issue its Q1 2025 quarterly earnings data before the market opens on Tuesday, May 6th. Analysts expect SOPHiA GENETICS to post earnings of ($0.21) per share and revenue of $16.76 million for the quarter. SOPHiA GENETICS has set its FY 2025 guidance at EPS.

SOPHiA GENETICS (NASDAQ:SOPHGet Free Report) last announced its quarterly earnings data on Tuesday, March 4th. The company reported ($0.23) EPS for the quarter, meeting analysts’ consensus estimates of ($0.23). The firm had revenue of $17.73 million for the quarter, compared to analyst estimates of $17.71 million. SOPHiA GENETICS had a negative return on equity of 55.06% and a negative net margin of 110.71%. On average, analysts expect SOPHiA GENETICS to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

SOPHiA GENETICS Trading Down 4.3 %

SOPH stock opened at $3.12 on Tuesday. The business has a fifty day moving average of $3.18 and a 200-day moving average of $3.37. The company has a market cap of $208.06 million, a P/E ratio of -2.86 and a beta of 1.02. SOPHiA GENETICS has a twelve month low of $2.58 and a twelve month high of $6.28. The company has a quick ratio of 3.59, a current ratio of 3.80 and a debt-to-equity ratio of 0.12.

Analyst Ratings Changes

Separately, BTIG Research set a $5.00 target price on shares of SOPHiA GENETICS in a research report on Thursday, March 6th.

View Our Latest Stock Report on SOPHiA GENETICS

About SOPHiA GENETICS

(Get Free Report)

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific.

Further Reading

Earnings History for SOPHiA GENETICS (NASDAQ:SOPH)

Receive News & Ratings for SOPHiA GENETICS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SOPHiA GENETICS and related companies with MarketBeat.com's FREE daily email newsletter.